Use of drugs to treat symptoms and acute conditions during pregnancy in outpatient care in Switzerland between 2014 and 2018: analysis of Swiss healthcare claims data
CONCLUSION: The observed pattern of claimed drugs during pregnancy is in line with existing treatment guidelines. Exposure to potentially teratogenic and fetotoxic drugs was small, but given the lack of recorded diagnosis, we cannot determine if their use was clinically indicated.PMID:34843179 | DOI:10.4414/smw.2021.w30048
Source: Swiss Medical Weekly - Category: General Medicine Authors: Eva Gerbier Sereina M Graber Marlene Rauch Carole A Marxer Christoph R Meier David Baud Ursula Winterfeld Eva Blozik Daniel Surbeki Julia Spoendlin Alice Panchaud Source Type: research
More News: Acid Reflux | Amoxicillin | Constipation | Databases & Libraries | Gastroenterology | Gastroesophageal Reflux Disease | General Medicine | GERD | Insurance | Men | Metoclopramide | Pain | Pregnancy | Proton Pump Inhibitors PPIs | Study | Switzerland Health | Zofran